P-100 - POPULATION PHARMACOKINETICS MODELING FOR FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE INHALATION POWDER IN A BIOEQUIVALENCE STUDY.
S. Li1, K. Feng2, J. Lee2, Y. Gong2, F. Wu2, B. Newman2, M. Yoon2, L. Fang2, L. Zhao2, J. Gobburu1; 1University of Maryland, Baltimore, MD, USA, 2US Food and Drug Administration, Silver Spring, MD, USA.